|Articles|February 18, 2009

Supplements and Featured Publications

  • New Paradigms in Comorbid Insomnia
  • Volume 15
  • Issue 1 Suppl

Participating Faculty

FACULTY

Christina S. McCrae, PhD

Associate Professor

Department of Clinical and Health Psychology

University of Florida

Gainesville, Florida

David N. Neubauer, MD

Associate Director

Department of Psychiatry and Behavioral Sciences

Johns Hopkins Sleep Disorders Center

Baltimore, Maryland

Thomas Roth, PhD

Director

Henry Ford Hospital Sleep Disorders and Research Center

Detroit, Michigan

FACULTY DISCLOSURES

These participants report relationships with the following organizations:

Christina S. McCrae, PhD

Grants: National Institutes of Health

David N. Neubauer, MD

Consultant/Advisory board: sanofi-aventis, Takeda Pharmaceuticals

North America

Lecturer: sanofi-aventis, Takeda Pharmaceuticals North America

Thomas Roth, PhD

Consultant: Abbott, Actelion, Arena, BTG, Cephalon, Evotec, Intec,

Intra-Cellular, Jazz, Merck, Neurim, Neurocrine, Neurogen, Organon,

Pfizer, Procter & Gamble, Sanofi, Schering-Plough, Sepracor, Shire,

Somaxon, Takeda, TransOral, Vanda

Sepracor

This supplement was supported by

Articles in this issue

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.


Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo